The impact of aging and smoking of the future burden of chronic obstructive pulmonary disease -: A model analysis in the Netherlands

被引:149
作者
Feenstra, TL
van Genugten, MLL
Hoogenveen, RT
Wouters, EF
Rutten-van Mölken, MPMH
机构
[1] Erasmus Univ, Inst Med Technol Assessment, NL-3000 DR Rotterdam, Netherlands
[2] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands
[3] Univ Hosp Maastricht, Dept Pulmonol, Maastricht, Netherlands
关键词
COPD; epidemiology; smoking; costs; model;
D O I
10.1164/ajrccm.164.4.2003167
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Chronic obstructive pulmonary disease (COPD) causes extensive disability, primarily among the elderly. On the World Health Organization ranking list of disability-adjusted life years (DALYs), COPD rises from the twelfth to the fifth place from 1990 to 2020. The purpose of this study is to single out the impact of changes in demography and in smoking behavior on COPD morbidity, mortality, and health care costs. A dynamic multistate life table model was used to compute projections for the Netherlands. Changes in the size and composition of the population cause COPD prevalence to increase from 21/1,000 in 1994 to 33/1,000 in 2015 for men, and from 10/1,000 to 23/1,000 for women. Changes in smoking behavior reduce the projected prevalence to 29/1,000 for men, but increase it to 25/1,000 for women. Total life years lost increase more than 60%, and DALYs lost increase 75%. Costs rise 90%; smokers cause approximately 90% of these costs. The model demonstrates the unavoidable increase in the burden of COPD, an increase that is larger for women than for men. The major causes of this increase are past smoking behavior and the aging of the population; changes in smoking behavior will have only a small effect in the nearby future.
引用
收藏
页码:590 / 596
页数:7
相关论文
共 32 条
  • [1] [Anonymous], 1990, HLTH BEN SMOK CESS R
  • [2] EFFECTS OF SMOKING INTERVENTION AND THE USE OF AN INHALED ANTICHOLINERGIC BRONCHODILATOR ON THE RATE OF DECLINE OF FEV(1) - THE LUNG HEALTH STUDY
    ANTHONISEN, NR
    CONNETT, JE
    KILEY, JP
    ALTOSE, MD
    BAILEY, WC
    BUIST, AS
    CONWAY, WA
    ENRIGHT, PL
    KANNER, RE
    OHARA, P
    OWENS, GR
    SCANLON, PD
    TASHKIN, DP
    WISE, RA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (19): : 1497 - 1505
  • [3] The health care costs of smoking
    Barendregt, JJ
    Bonneux, L
    van der Maas, PJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (15) : 1052 - 1057
  • [4] LONGITUDINAL CHANGES IN FORCED EXPIRATORY VOLUME IN ONE 2ND IN ADULTS - EFFECTS OF SMOKING AND SMOKING CESSATION
    CAMILLI, AE
    BURROWS, B
    KNUDSON, RJ
    LYLE, SK
    LEBOWITZ, MD
    [J]. AMERICAN REVIEW OF RESPIRATORY DISEASE, 1987, 135 (04): : 794 - 799
  • [5] CELLI BR, 1995, AM J RESP CRIT CARE, V152, pS77
  • [6] AN OPTIMAL PARALLEL ALGORITHM FOR DETECTING WEAK VISIBILITY OF A SIMPLE POLYGON
    CHEN, DZ
    [J]. INTERNATIONAL JOURNAL OF COMPUTATIONAL GEOMETRY & APPLICATIONS, 1995, 5 (1-2) : 93 - 124
  • [7] *GIP, 1999, GIP GEN INF VAND GIP
  • [8] A 1-year community-based health economic study of ciprofloxacin vs usual antibiotic treatment in acute exacerbations of chronic bronchitis - The Canadian Ciprofloxacin Health Economic Study Group
    Grossman, R
    Mukherjee, J
    Vaughan, D
    Eastwood, C
    Cook, R
    LaForge, J
    Lampron, N
    [J]. CHEST, 1998, 113 (01) : 131 - 141
  • [9] Comparison of outcome measures for patients with chronic obstructive pulmonary disease (COPD) in an outpatient setting
    Harper, R
    Brazier, JE
    Waterhouse, JC
    Walters, SJ
    Jones, NMB
    Howard, P
    [J]. THORAX, 1997, 52 (10) : 879 - 887
  • [10] Trends in smoking-related diseases - Why smoking cessation is still the best medicine
    Hays, JT
    Dale, LC
    Hurt, RD
    Croghan, IT
    [J]. POSTGRADUATE MEDICINE, 1998, 104 (06) : 56 - +